Michael Wilson
Concepts (292)
Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Emergency Service, Hospital | 61 | 2026 | 530 | 10.190 |
Why?
| | Mental Disorders | 21 | 2025 | 446 | 5.880 |
Why?
| | Psychomotor Agitation | 18 | 2022 | 51 | 5.440 |
Why?
| | Antipsychotic Agents | 16 | 2022 | 233 | 4.510 |
Why?
| | Mass Screening | 11 | 2025 | 362 | 2.740 |
Why?
| | Benzodiazepines | 12 | 2017 | 72 | 2.480 |
Why?
| | Emergency Medicine | 8 | 2022 | 50 | 2.340 |
Why?
| | Emergency Services, Psychiatric | 6 | 2020 | 13 | 1.930 |
Why?
| | Alcoholic Intoxication | 8 | 2026 | 30 | 1.910 |
Why?
| | Haloperidol | 6 | 2022 | 46 | 1.860 |
Why?
| | Risk Assessment | 9 | 2020 | 1368 | 1.740 |
Why?
| | Emergencies | 5 | 2022 | 78 | 1.270 |
Why?
| | Humans | 82 | 2026 | 53230 | 1.210 |
Why?
| | Risperidone | 3 | 2017 | 25 | 1.180 |
Why?
| | Mental Health | 2 | 2023 | 248 | 1.140 |
Why?
| | Adult | 36 | 2026 | 14534 | 1.070 |
Why?
| | Suicidal Ideation | 4 | 2022 | 120 | 1.040 |
Why?
| | Psychotic Disorders | 2 | 2019 | 138 | 0.990 |
Why?
| | Opioid-Related Disorders | 3 | 2021 | 426 | 0.970 |
Why?
| | Vital Signs | 2 | 2017 | 19 | 0.940 |
Why?
| | Consensus | 6 | 2025 | 206 | 0.920 |
Why?
| | Peer Group | 1 | 2025 | 63 | 0.890 |
Why?
| | Male | 41 | 2026 | 27435 | 0.840 |
Why?
| | Suicide | 5 | 2026 | 89 | 0.800 |
Why?
| | Delirium | 4 | 2019 | 49 | 0.790 |
Why?
| | Female | 39 | 2026 | 28782 | 0.780 |
Why?
| | Middle Aged | 27 | 2026 | 13419 | 0.770 |
Why?
| | Practice Guidelines as Topic | 5 | 2021 | 502 | 0.760 |
Why?
| | Substance-Related Disorders | 5 | 2020 | 630 | 0.710 |
Why?
| | Thiazoles | 3 | 2022 | 52 | 0.690 |
Why?
| | Hepatitis C, Chronic | 2 | 2013 | 89 | 0.660 |
Why?
| | Thyroid Crisis | 2 | 2017 | 6 | 0.660 |
Why?
| | Piperazines | 3 | 2022 | 125 | 0.650 |
Why?
| | Guideline Adherence | 1 | 2021 | 143 | 0.630 |
Why?
| | Randomized Controlled Trials as Topic | 3 | 2020 | 630 | 0.620 |
Why?
| | Diagnosis, Differential | 10 | 2025 | 1038 | 0.610 |
Why?
| | Length of Stay | 3 | 2025 | 684 | 0.600 |
Why?
| | Nurses | 1 | 2020 | 58 | 0.600 |
Why?
| | Prescription Drug Misuse | 1 | 2019 | 37 | 0.590 |
Why?
| | Preventive Health Services | 1 | 2019 | 53 | 0.580 |
Why?
| | Droperidol | 2 | 2015 | 7 | 0.580 |
Why?
| | Drug Monitoring | 1 | 2019 | 81 | 0.580 |
Why?
| | Drug Therapy, Combination | 7 | 2017 | 405 | 0.580 |
Why?
| | Retrospective Studies | 16 | 2026 | 6819 | 0.580 |
Why?
| | Geriatrics | 1 | 2019 | 42 | 0.570 |
Why?
| | Schizophrenia | 2 | 2019 | 254 | 0.560 |
Why?
| | Informed Consent | 1 | 2019 | 94 | 0.560 |
Why?
| | Anesthetics, Dissociative | 2 | 2015 | 14 | 0.540 |
Why?
| | Pilot Projects | 5 | 2025 | 726 | 0.540 |
Why?
| | Aggression | 2 | 2015 | 52 | 0.530 |
Why?
| | Pain Management | 1 | 2019 | 185 | 0.530 |
Why?
| | Physicians | 2 | 2020 | 242 | 0.530 |
Why?
| | Oxygen | 4 | 2013 | 338 | 0.530 |
Why?
| | Pheochromocytoma | 1 | 2017 | 34 | 0.520 |
Why?
| | Substance Abuse Detection | 1 | 2017 | 93 | 0.520 |
Why?
| | Patient Selection | 1 | 2019 | 273 | 0.520 |
Why?
| | Psychological Tests | 1 | 2017 | 52 | 0.520 |
Why?
| | Medical History Taking | 1 | 2017 | 47 | 0.520 |
Why?
| | Age Factors | 2 | 2017 | 1136 | 0.510 |
Why?
| | Hypotension | 1 | 2017 | 62 | 0.510 |
Why?
| | Attitude of Health Personnel | 1 | 2020 | 371 | 0.500 |
Why?
| | Psychiatric Status Rating Scales | 1 | 2018 | 325 | 0.500 |
Why?
| | Physical Examination | 1 | 2017 | 96 | 0.500 |
Why?
| | Analgesics, Opioid | 2 | 2019 | 622 | 0.500 |
Why?
| | Neuroleptic Malignant Syndrome | 1 | 2016 | 3 | 0.490 |
Why?
| | Patient Acceptance of Health Care | 1 | 2020 | 379 | 0.490 |
Why?
| | Steroids | 1 | 2016 | 61 | 0.490 |
Why?
| | Administration, Oral | 5 | 2017 | 456 | 0.480 |
Why?
| | Databases, Factual | 1 | 2019 | 742 | 0.470 |
Why?
| | Serotonin Syndrome | 1 | 2015 | 5 | 0.470 |
Why?
| | Ketamine | 2 | 2017 | 62 | 0.460 |
Why?
| | Injections, Intramuscular | 5 | 2020 | 55 | 0.460 |
Why?
| | Cocaine-Related Disorders | 1 | 2017 | 206 | 0.460 |
Why?
| | Disease Management | 2 | 2016 | 187 | 0.450 |
Why?
| | Acute Disease | 6 | 2025 | 393 | 0.440 |
Why?
| | Young Adult | 11 | 2026 | 4511 | 0.440 |
Why?
| | Depressive Disorder | 3 | 2013 | 336 | 0.430 |
Why?
| | Alcoholism | 2 | 2016 | 242 | 0.430 |
Why?
| | Pain, Referred | 1 | 2014 | 1 | 0.420 |
Why?
| | Toothache | 1 | 2014 | 2 | 0.420 |
Why?
| | Facial Pain | 1 | 2014 | 10 | 0.420 |
Why?
| | Hepatitis B, Chronic | 1 | 2013 | 13 | 0.400 |
Why?
| | Psychotherapy | 3 | 2025 | 117 | 0.400 |
Why?
| | Substance Withdrawal Syndrome | 3 | 2021 | 168 | 0.390 |
Why?
| | Fasciitis, Necrotizing | 1 | 2012 | 7 | 0.390 |
Why?
| | Aged | 12 | 2025 | 10429 | 0.360 |
Why?
| | Prospective Studies | 6 | 2022 | 2411 | 0.360 |
Why?
| | Blood Pressure | 4 | 2017 | 518 | 0.360 |
Why?
| | Headache | 2 | 2025 | 75 | 0.350 |
Why?
| | Suicide, Attempted | 3 | 2026 | 85 | 0.340 |
Why?
| | Pregnancy Complications | 1 | 2015 | 406 | 0.340 |
Why?
| | United States | 9 | 2025 | 5409 | 0.340 |
Why?
| | Social Adjustment | 1 | 2010 | 29 | 0.310 |
Why?
| | Myocardial Infarction | 1 | 2014 | 445 | 0.310 |
Why?
| | Heart Rate | 3 | 2017 | 314 | 0.300 |
Why?
| | HIV Infections | 1 | 2013 | 402 | 0.290 |
Why?
| | Geriatric Assessment | 2 | 2019 | 108 | 0.290 |
Why?
| | Delivery of Health Care | 5 | 2023 | 317 | 0.290 |
Why?
| | Social Support | 1 | 2010 | 272 | 0.270 |
Why?
| | Pandemics | 3 | 2021 | 595 | 0.270 |
Why?
| | Anxiety | 3 | 2020 | 321 | 0.260 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 246 | 0.260 |
Why?
| | Sweating | 2 | 2017 | 13 | 0.260 |
Why?
| | Advisory Committees | 2 | 2017 | 75 | 0.250 |
Why?
| | Drug Interactions | 3 | 2012 | 196 | 0.250 |
Why?
| | Emergency Medical Services | 2 | 2022 | 122 | 0.240 |
Why?
| | Patient Discharge | 3 | 2023 | 325 | 0.240 |
Why?
| | Predictive Value of Tests | 2 | 2019 | 934 | 0.240 |
Why?
| | Insurance Claim Review | 1 | 2025 | 42 | 0.230 |
Why?
| | Conversion Disorder | 1 | 2025 | 3 | 0.230 |
Why?
| | Risk Factors | 7 | 2025 | 4017 | 0.230 |
Why?
| | Sinus Thrombosis, Intracranial | 1 | 2025 | 18 | 0.220 |
Why?
| | Muscle Weakness | 1 | 2025 | 46 | 0.220 |
Why?
| | Restraint, Physical | 2 | 2022 | 20 | 0.220 |
Why?
| | Voice | 1 | 2025 | 28 | 0.220 |
Why?
| | California | 3 | 2019 | 93 | 0.220 |
Why?
| | Psychotropic Drugs | 1 | 2025 | 79 | 0.220 |
Why?
| | Oxytocin | 2 | 2013 | 18 | 0.200 |
Why?
| | Fever | 2 | 2016 | 112 | 0.200 |
Why?
| | Feasibility Studies | 2 | 2022 | 411 | 0.190 |
Why?
| | Muscle, Smooth, Vascular | 1 | 2023 | 135 | 0.190 |
Why?
| | Aftercare | 2 | 2023 | 73 | 0.180 |
Why?
| | Nephrectomy | 1 | 2022 | 81 | 0.180 |
Why?
| | Antidepressive Agents | 2 | 2013 | 177 | 0.180 |
Why?
| | Abdominal Wall | 1 | 2021 | 13 | 0.180 |
Why?
| | Dextroamphetamine | 1 | 2021 | 36 | 0.180 |
Why?
| | Insufflation | 1 | 2021 | 12 | 0.180 |
Why?
| | Referral and Consultation | 2 | 2021 | 299 | 0.170 |
Why?
| | Antidepressive Agents, Second-Generation | 2 | 2017 | 27 | 0.170 |
Why?
| | Amphetamine-Related Disorders | 1 | 2021 | 93 | 0.170 |
Why?
| | Controlled Clinical Trials as Topic | 1 | 2020 | 21 | 0.160 |
Why?
| | Akathisia, Drug-Induced | 1 | 2020 | 11 | 0.160 |
Why?
| | Myocardial Ischemia | 1 | 2021 | 129 | 0.160 |
Why?
| | Emergency Nursing | 1 | 2020 | 8 | 0.160 |
Why?
| | Crisis Intervention | 1 | 2020 | 11 | 0.160 |
Why?
| | Narcotic Antagonists | 1 | 2021 | 150 | 0.160 |
Why?
| | Methamphetamine | 1 | 2021 | 190 | 0.150 |
Why?
| | Adolescent | 6 | 2026 | 6907 | 0.150 |
Why?
| | Laparoscopy | 1 | 2021 | 180 | 0.150 |
Why?
| | Analysis of Variance | 2 | 2011 | 547 | 0.150 |
Why?
| | Depression | 1 | 2025 | 621 | 0.150 |
Why?
| | Death, Sudden | 1 | 2019 | 9 | 0.150 |
Why?
| | Central Nervous System Stimulants | 1 | 2021 | 201 | 0.150 |
Why?
| | Meningoencephalitis | 1 | 2019 | 7 | 0.150 |
Why?
| | Meningitis, Cryptococcal | 1 | 2019 | 10 | 0.150 |
Why?
| | Loxapine | 1 | 2019 | 2 | 0.150 |
Why?
| | Ethanol | 2 | 2013 | 338 | 0.150 |
Why?
| | Lorazepam | 1 | 2019 | 13 | 0.150 |
Why?
| | Buprenorphine | 1 | 2021 | 162 | 0.150 |
Why?
| | Ethics, Research | 1 | 2019 | 39 | 0.140 |
Why?
| | Ambulatory Care Facilities | 1 | 2019 | 121 | 0.140 |
Why?
| | Child | 5 | 2019 | 7379 | 0.140 |
Why?
| | Hypercalcemia | 1 | 2018 | 34 | 0.140 |
Why?
| | Hypnotics and Sedatives | 3 | 2017 | 74 | 0.140 |
Why?
| | Hospitals, University | 2 | 2018 | 75 | 0.140 |
Why?
| | Health Services Research | 1 | 2019 | 153 | 0.140 |
Why?
| | Stress, Physiological | 1 | 2019 | 184 | 0.140 |
Why?
| | Psychiatry | 1 | 2019 | 104 | 0.140 |
Why?
| | Respiratory Rate | 1 | 2017 | 7 | 0.140 |
Why?
| | Comorbidity | 2 | 2017 | 638 | 0.140 |
Why?
| | Qualitative Research | 1 | 2020 | 384 | 0.130 |
Why?
| | Goals | 1 | 2017 | 45 | 0.130 |
Why?
| | Prisoners | 1 | 2019 | 106 | 0.130 |
Why?
| | Adrenal Gland Neoplasms | 1 | 2017 | 49 | 0.130 |
Why?
| | Pneumonia, Viral | 1 | 2020 | 177 | 0.130 |
Why?
| | Physician-Patient Relations | 1 | 2018 | 146 | 0.130 |
Why?
| | Bipolar Disorder | 1 | 2019 | 201 | 0.130 |
Why?
| | Coronavirus Infections | 1 | 2020 | 188 | 0.130 |
Why?
| | Korsakoff Syndrome | 1 | 2016 | 1 | 0.130 |
Why?
| | Veterans | 1 | 2023 | 580 | 0.130 |
Why?
| | Patient Satisfaction | 1 | 2018 | 292 | 0.130 |
Why?
| | Regression Analysis | 1 | 2017 | 391 | 0.120 |
Why?
| | Muscle Rigidity | 1 | 2016 | 1 | 0.120 |
Why?
| | Vitamin B Complex | 1 | 2016 | 22 | 0.120 |
Why?
| | Thiamine | 1 | 2016 | 15 | 0.120 |
Why?
| | Communication | 1 | 2018 | 263 | 0.120 |
Why?
| | Chronic Pain | 1 | 2019 | 183 | 0.120 |
Why?
| | Catatonia | 1 | 2016 | 8 | 0.120 |
Why?
| | Health Policy | 1 | 2017 | 165 | 0.120 |
Why?
| | Polypharmacy | 1 | 2015 | 16 | 0.120 |
Why?
| | Anti-Inflammatory Agents | 1 | 2016 | 164 | 0.110 |
Why?
| | Retreatment | 1 | 2015 | 60 | 0.110 |
Why?
| | Cross-Sectional Studies | 3 | 2025 | 1723 | 0.110 |
Why?
| | Chronic Disease | 1 | 2017 | 580 | 0.110 |
Why?
| | Dibenzothiazepines | 1 | 2014 | 10 | 0.110 |
Why?
| | Jaw | 1 | 2014 | 4 | 0.110 |
Why?
| | Tomography, X-Ray Computed | 2 | 2025 | 1180 | 0.100 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 1 | 2016 | 152 | 0.100 |
Why?
| | Pregnancy | 2 | 2025 | 2608 | 0.100 |
Why?
| | Diagnosis, Dual (Psychiatry) | 1 | 2013 | 42 | 0.100 |
Why?
| | Aged, 80 and over | 2 | 2019 | 3494 | 0.100 |
Why?
| | Quinolones | 1 | 2014 | 52 | 0.100 |
Why?
| | Cohort Studies | 1 | 2017 | 1557 | 0.100 |
Why?
| | Hand Disinfection | 1 | 2013 | 9 | 0.100 |
Why?
| | Breath Tests | 1 | 2013 | 39 | 0.100 |
Why?
| | Drug Prescriptions | 1 | 2014 | 116 | 0.100 |
Why?
| | Leukocyte Count | 1 | 2012 | 71 | 0.100 |
Why?
| | Drug Overdose | 1 | 2015 | 170 | 0.100 |
Why?
| | Sodium | 1 | 2012 | 89 | 0.090 |
Why?
| | Creatinine | 1 | 2012 | 158 | 0.090 |
Why?
| | Sex Factors | 1 | 2015 | 747 | 0.090 |
Why?
| | Lactic Acid | 1 | 2012 | 78 | 0.090 |
Why?
| | Forensic Psychiatry | 1 | 2012 | 6 | 0.090 |
Why?
| | Hemoglobins | 1 | 2012 | 114 | 0.090 |
Why?
| | Sodium Bicarbonate | 1 | 2012 | 9 | 0.090 |
Why?
| | C-Reactive Protein | 1 | 2012 | 152 | 0.090 |
Why?
| | Acidosis | 1 | 2012 | 37 | 0.090 |
Why?
| | Hypothermia, Induced | 1 | 2012 | 46 | 0.090 |
Why?
| | Fluid Therapy | 1 | 2012 | 79 | 0.090 |
Why?
| | Anti-Dyskinesia Agents | 1 | 2010 | 1 | 0.080 |
Why?
| | Behavior Therapy | 1 | 2012 | 185 | 0.080 |
Why?
| | Alcohol-Related Disorders | 1 | 2010 | 44 | 0.080 |
Why?
| | Sick Role | 1 | 2010 | 12 | 0.080 |
Why?
| | Personality Inventory | 1 | 2010 | 50 | 0.080 |
Why?
| | Blood Glucose | 1 | 2012 | 490 | 0.080 |
Why?
| | Liver Function Tests | 1 | 2010 | 47 | 0.080 |
Why?
| | Interferons | 1 | 2010 | 39 | 0.080 |
Why?
| | Religion and Psychology | 1 | 2010 | 28 | 0.080 |
Why?
| | Clinical Trials as Topic | 1 | 2012 | 466 | 0.080 |
Why?
| | Viral Load | 1 | 2010 | 83 | 0.080 |
Why?
| | Social Environment | 1 | 2010 | 82 | 0.080 |
Why?
| | Psychometrics | 1 | 2010 | 244 | 0.070 |
Why?
| | Transportation of Patients | 1 | 2008 | 39 | 0.070 |
Why?
| | Antiviral Agents | 1 | 2010 | 179 | 0.070 |
Why?
| | Genetic Predisposition to Disease | 1 | 2010 | 533 | 0.060 |
Why?
| | Hydrocortisone | 2 | 2019 | 113 | 0.060 |
Why?
| | Double-Blind Method | 2 | 2021 | 729 | 0.060 |
Why?
| | Alberta | 1 | 2026 | 5 | 0.060 |
Why?
| | Evidence-Based Medicine | 2 | 2017 | 275 | 0.060 |
Why?
| | Self-Injurious Behavior | 1 | 2026 | 34 | 0.060 |
Why?
| | Delphi Technique | 1 | 2025 | 71 | 0.060 |
Why?
| | Glasgow Coma Scale | 1 | 2025 | 43 | 0.060 |
Why?
| | Canada | 1 | 2025 | 112 | 0.050 |
Why?
| | Ferrets | 1 | 2023 | 7 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 241 | 0.050 |
Why?
| | Calcium-Binding Proteins | 1 | 2023 | 58 | 0.050 |
Why?
| | Quality of Life | 1 | 2010 | 902 | 0.050 |
Why?
| | Myocytes, Smooth Muscle | 1 | 2023 | 96 | 0.050 |
Why?
| | Research Design | 1 | 2025 | 373 | 0.050 |
Why?
| | Stroke | 1 | 2008 | 520 | 0.050 |
Why?
| | Muscle Contraction | 1 | 2023 | 114 | 0.050 |
Why?
| | Calcium | 1 | 2023 | 373 | 0.050 |
Why?
| | Severity of Illness Index | 1 | 2025 | 1049 | 0.040 |
Why?
| | United States Department of Veterans Affairs | 1 | 2023 | 295 | 0.040 |
Why?
| | Quality of Health Care | 1 | 2023 | 189 | 0.040 |
Why?
| | RNA, Viral | 1 | 2021 | 123 | 0.040 |
Why?
| | Mice, Knockout | 1 | 2023 | 910 | 0.040 |
Why?
| | Primary Health Care | 1 | 2025 | 404 | 0.040 |
Why?
| | Dynorphins | 1 | 2019 | 4 | 0.040 |
Why?
| | Police | 1 | 2019 | 4 | 0.040 |
Why?
| | Glycopeptides | 1 | 2019 | 12 | 0.040 |
Why?
| | Sampling Studies | 1 | 2019 | 38 | 0.040 |
Why?
| | Diagnostic and Statistical Manual of Mental Disorders | 1 | 2019 | 77 | 0.040 |
Why?
| | Diuretics, Osmotic | 1 | 2019 | 4 | 0.040 |
Why?
| | Mannitol | 1 | 2019 | 14 | 0.040 |
Why?
| | Consciousness Disorders | 1 | 2019 | 8 | 0.040 |
Why?
| | Intracranial Hypertension | 1 | 2019 | 31 | 0.040 |
Why?
| | Cryptococcus neoformans | 1 | 2019 | 26 | 0.040 |
Why?
| | Guidelines as Topic | 1 | 2019 | 111 | 0.040 |
Why?
| | Norepinephrine | 1 | 2019 | 106 | 0.040 |
Why?
| | Education | 1 | 2019 | 39 | 0.040 |
Why?
| | Text Messaging | 1 | 2018 | 23 | 0.040 |
Why?
| | Telephone | 1 | 2018 | 70 | 0.040 |
Why?
| | Magnetic Resonance Imaging | 1 | 2025 | 1583 | 0.030 |
Why?
| | Conscious Sedation | 1 | 2017 | 19 | 0.030 |
Why?
| | Dementia | 1 | 2019 | 141 | 0.030 |
Why?
| | Health Personnel | 1 | 2020 | 259 | 0.030 |
Why?
| | Emergency Treatment | 1 | 2017 | 29 | 0.030 |
Why?
| | Excitatory Amino Acid Antagonists | 1 | 2017 | 46 | 0.030 |
Why?
| | Flumazenil | 1 | 2016 | 4 | 0.030 |
Why?
| | Psychoses, Substance-Induced | 1 | 2016 | 6 | 0.030 |
Why?
| | Phenobarbital | 1 | 2016 | 17 | 0.030 |
Why?
| | Delusions | 1 | 2016 | 8 | 0.030 |
Why?
| | Patient Readmission | 1 | 2018 | 251 | 0.030 |
Why?
| | Case-Control Studies | 1 | 2019 | 1212 | 0.030 |
Why?
| | Hospital Charges | 1 | 2014 | 47 | 0.030 |
Why?
| | Mental Health Services | 1 | 2017 | 233 | 0.030 |
Why?
| | Theory of Mind | 1 | 2013 | 1 | 0.030 |
Why?
| | Interview, Psychological | 1 | 2013 | 24 | 0.030 |
Why?
| | Phobic Disorders | 1 | 2013 | 17 | 0.020 |
Why?
| | Mice | 1 | 2023 | 5982 | 0.020 |
Why?
| | Behavior | 1 | 2013 | 46 | 0.020 |
Why?
| | Saliva | 1 | 2013 | 56 | 0.020 |
Why?
| | False Positive Reactions | 1 | 2013 | 66 | 0.020 |
Why?
| | Social Behavior | 1 | 2013 | 74 | 0.020 |
Why?
| | Affect | 1 | 2013 | 107 | 0.020 |
Why?
| | Longitudinal Studies | 1 | 2014 | 774 | 0.020 |
Why?
| | Neuropsychological Tests | 1 | 2013 | 345 | 0.020 |
Why?
| | Cognition | 1 | 2013 | 346 | 0.020 |
Why?
| | Animals | 1 | 2023 | 13526 | 0.020 |
Why?
| | Child, Preschool | 1 | 2014 | 4162 | 0.010 |
Why?
| | Time Factors | 1 | 2008 | 2991 | 0.010 |
Why?
|
|
Wilson's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|